CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,049,000 | -1.2% | 728,385 | 0.0% | 0.39% | +35.0% |
| Q1 2022 | $18,261,000 | -51.8% | 728,385 | -30.0% | 0.29% | -40.9% |
| Q4 2021 | $37,866,000 | +112.9% | 1,040,000 | 0.0% | 0.48% | +106.0% |
| Q3 2021 | $17,784,000 | -5.3% | 1,040,000 | -25.9% | 0.24% | -6.7% |
| Q2 2021 | $18,786,000 | -34.5% | 1,403,000 | +150.5% | 0.25% | -40.7% |
| Q1 2021 | $28,694,000 | +19.7% | 560,000 | +44.7% | 0.42% | +15.8% |
| Q4 2020 | $23,963,000 | +47.2% | 387,000 | +30.3% | 0.37% | +15.0% |
| Q3 2020 | $16,276,000 | +61.6% | 297,000 | +69.7% | 0.32% | +45.7% |
| Q2 2020 | $10,069,000 | – | 175,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |